��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
矽創(8016)
月營收
季盈餘
2025/03/01
192.5元 (矽創股價)
2025/03/01
33.98% (年增率)
1,685百萬元 (營收)
矽創(8016) 年度營收走勢圖
矽創(8016)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
1,685,266
35.44%
1,257,811
33.98%
4,332,354
4.41%
114/02
1,244,312
-11.30%
1,259,483
-1.20%
2,647,088
-8.45%
114/01
1,402,776
-10.49%
1,631,935
-14.04%
1,402,776
-14.04%
113/12
1,567,241
2.97%
1,471,728
6.49%
17,826,505
6.60%
113/11
1,522,102
-0.35%
1,517,627
0.29%
16,259,264
6.61%
113/10
1,527,520
-3.89%
1,521,809
0.38%
14,737,162
7.31%
113/09
1,589,405
-0.45%
1,432,119
10.98%
13,209,642
8.17%
113/08
1,596,603
6.63%
1,390,834
14.79%
11,620,237
7.80%
113/07
1,497,331
9.30%
1,378,595
8.61%
10,023,634
6.76%
113/06
1,369,978
-12.67%
1,339,633
2.27%
8,526,303
6.44%
113/05
1,568,650
9.05%
1,537,374
2.03%
7,156,325
7.28%
113/04
1,438,446
14.36%
1,532,556
-6.14%
5,587,675
8.85%
113/03
1,257,811
-0.13%
1,499,604
-16.12%
4,149,229
15.24%
113/02
1,259,483
-22.82%
1,057,548
19.09%
2,891,418
37.62%
113/01
1,631,935
10.89%
1,043,464
56.40%
1,631,935
56.40%
112/12
1,471,728
-3.02%
1,158,134
27.08%
16,722,891
-7.24%
112/11
1,517,627
-0.27%
1,271,109
19.39%
15,251,163
-9.59%
112/10
1,521,809
6.26%
1,402,178
8.53%
13,733,536
-11.96%
112/09
1,432,119
2.97%
1,366,125
4.83%
12,211,727
-13.98%
112/08
1,390,834
0.89%
1,358,220
2.40%
10,779,608
-15.98%
112/07
1,378,595
2.91%
1,341,235
2.79%
9,388,774
-18.16%
112/06
1,339,633
-12.86%
1,195,922
12.02%
8,010,179
-20.93%
112/05
1,537,374
0.31%
1,597,462
-3.76%
6,670,546
-25.34%
112/04
1,532,556
2.20%
1,743,832
-12.12%
5,133,172
-30.04%
112/03
1,499,604
41.80%
1,874,061
-19.98%
3,600,616
-35.63%
112/02
1,057,548
1.35%
1,835,273
-42.38%
2,101,012
-43.51%
112/01
1,043,464
-9.90%
1,884,275
-44.62%
1,043,464
-44.62%
111/12
1,158,134
-8.89%
1,951,479
-40.65%
18,027,827
-19.00%
111/11
1,271,109
-9.35%
2,008,761
-36.72%
16,869,693
-16.92%
111/10
1,402,178
2.64%
2,132,460
-34.25%
15,598,584
-14.74%
111/09
1,366,125
0.58%
2,152,675
-36.54%
14,196,406
-12.17%
111/08
1,358,220
1.27%
2,206,743
-38.45%
12,830,281
-8.42%
111/07
1,341,235
12.15%
2,226,396
-39.76%
11,472,061
-2.81%
111/06
1,195,922
-25.14%
1,866,265
-35.92%
10,130,826
5.78%
111/05
1,597,462
-8.39%
1,902,983
-16.05%
8,934,904
15.87%
111/04
1,743,832
-6.95%
1,765,268
-1.21%
7,337,442
26.34%
111/03
1,874,061
2.11%
1,554,779
20.54%
5,593,610
38.37%
111/02
1,835,273
-2.60%
3,719,548
111/01
1,884,275
-3.44%
1,884,275
110/12
1,951,479
-2.85%
22,255,670
110/11
2,008,761
-5.80%
20,304,191
110/10
2,132,460
-0.94%
18,295,430
110/09
2,152,675
-2.45%
16,162,970
110/08
2,206,743
-0.88%
14,010,295
110/07
2,226,396
19.30%
11,803,553
110/06
1,866,265
-1.93%
9,577,156
110/05
1,902,983
7.80%
7,710,891
110/04
1,765,268
13.54%
5,807,908
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
